These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9260314)

  • 1. [Coronary disease. Prevention and current therapeutic concepts].
    Fortschr Med Suppl; 1991; 112():1-15. PubMed ID: 9260314
    [No Abstract]   [Full Text] [Related]  

  • 2. Aggressive medical therapy for the prevention and treatment of coronary artery disease.
    Malloy MJ; Kane JP
    Dis Mon; 1998 Jan; 44(1):1-40. PubMed ID: 9457050
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of hypercholesterolaemia in the patient with diabetes.
    Packard C; Olsson AG
    Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDL cholesterol: physiology, pathophysiology, and management.
    Link JJ; Rohatgi A; de Lemos JA
    Curr Probl Cardiol; 2007 May; 32(5):268-314. PubMed ID: 17481993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of the guideline for hyperlipidemia to primary care clinic].
    Teramoto T
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():483-91. PubMed ID: 11347118
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipoprotein analysis.
    Colyar MR
    Adv Nurse Pract; 2002 May; 10(5):30-2. PubMed ID: 12420528
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical inquiries. What is the best strategy for monitoring the lipid-lowering effects of medical therapy used for the primary prevention of coronary artery disease (CAD)?
    Sherrod JP; Krist A
    J Fam Pract; 2001 Nov; 50(11):928. PubMed ID: 11711006
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cholesterol and vascular risk].
    Leizorovicz A
    Rev Prat; 1988 Feb; 38(5 Suppl):39-42. PubMed ID: 3281238
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of hyperlipidemia].
    Yoshino G
    Rinsho Byori; 2002 Mar; 50(3):254-61. PubMed ID: 11985052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipid metabolism disorder: detection and treatment. 5: Treatment of hyperlipidemia in manifest coronary heart disease, diabetes mellitus and hypertension. National cholesterol initiative].
    Assmann G
    Fortschr Med; 1991 Jun; 109(17):361-3. PubMed ID: 1885117
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long-term results of the use of different modifications of the partial ileal shunt operation in the treatment of patients with atherogenic dyslipoproteinemias].
    Mirchuk KK; Lebedev LV; Sedletskiĭ IuI
    Vestn Khir Im I I Grek; 2001; 160(1):29-32. PubMed ID: 11258320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyslipidemia and coronary artery disease.
    Genest JG
    Can J Cardiol; 2000 Jan; 16 Suppl A():3A-4A. PubMed ID: 10653923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease.
    Ravindran R; Krishnan LK
    Pathophysiol Haemost Thromb; 2007; 36(1):45-51. PubMed ID: 18332614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherosclerosis prevention for the next decade: risk assessment beyond low density lipoprotein cholesterol.
    Lamarche B; Lewis GF
    Can J Cardiol; 1998 Jun; 14(6):841-51. PubMed ID: 9676170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lipid risk factors of atherosclerosis: who, when, how to treat?].
    Foubert L; Dejager S; Bruckert E; Turpin G
    Ann Endocrinol (Paris); 1997; 58(4):275-82. PubMed ID: 9436473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High blood cholesterol.
    National Heart, Lung and Blood Institute
    Nutr Clin Care; 2003; 6(3):108-14. PubMed ID: 14979453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rising to the challenge of the new NCEP ATP III guidelines: exceeding current therapeutic limitations.
    Brewer HB
    Am J Manag Care; 2002 Feb; 8(2 Suppl):S23-8; discussion S45-7. PubMed ID: 11855698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipids.
    Beattie S
    RN; 2009 Sep; 72(9):16-8, 20-1. PubMed ID: 19839095
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
    Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.